- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Available formulations
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Dosages
| Cough |
|---|
|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
Unknown frequency: Dystonia, especially in children [SmPC Silomat® DMP]
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
In children, serious adverse events may occur in the event of an overdose, including neurological disorders. Caregivers should be instructed not to exceed the recommended dose. (SmPC easybronchial STOP JUNIOR)
Chronic cough may be an early symptom of bronchial asthma, therefore dextromethorphan is not indicated for the attenuation of this cough, particularly in children.
Cases of abuse and dependence on dextromethorphan have been reported. Caution is particularly advised in adolescents and young adults with a history of drug abuse or psychoactive substance use. (SmPC Silomat DMP)
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
References
- Qualiphar, SmPC Tussipect (RVG 19939) 9-10-2019, www.geneesmiddeleninformatiebank.nl
- STADA Consumer Health Deutschland GmbH, SmPC Silomat® DMP gegen Reizhusten, Lutschpastillen (49060.00.00), 06/2022
- Easypharm OTC GmbH, SmPC easybronchial STOP JUNIOR Sirup 1,5 mg/mL (136709), aufgerufen am 21.06.2023, https://aspregister.basg.gv.at/aspregister/faces/aspregister.jspx
- Teva B.V., SmPC Tussastopp-Lösung zum Einnehmen (1-27312), aufgerufen am 21.06.2023, https://aspregister.basg.gv.at/aspregister/faces/aspregister.jspx
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Changes
Changes
